FDA Inspection 1172990 — South Texas Blood & Tissue Center
The FDA completed an inspection of South Texas Blood & Tissue Center on Jun 9, 2022 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 9, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- San Antonio, TX (United States)